LDHD Antikörper (N-Term)
Kurzübersicht für LDHD Antikörper (N-Term) (ABIN6989657)
Target
Alle LDHD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- LDHD Monoclonal Antibody
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- Synthetic Peptide within N-terminal human LDHD.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000), IHC-P(1:20-100), IF(ICC)(1:50-200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- LDHD (Lactate Dehydrogenase D (LDHD))
-
Andere Bezeichnung
- LDHD
-
Hintergrund
-
Synonyms: D lactate dehydrogenase antibody, DLD antibody, Lactate dehydrogenase D antibody, Ldhd antibody, LDHD_HUMAN antibody, MGC57726 antibody, mitochondrial antibody, Probable D lactate dehydrogenase mitochondrial antibody, Probable D-lactate dehydrogenase antibody
Background: LDHD belongs to the D-isomer specific 2-hydroxyacid dehydrogenase family. D-lactate and D-glycerate dehydrogenase activities have been found in a similar protein in yeast. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified.
-
Gen-ID
- 197257
-
UniProt
- Q86WU2
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-